{"podcast":{"title":"The BioHub - by Avetix","slug":"the-biohub-by-avetix-7252289","podcast_index_feed_id":7252289,"rss_url":"https://anchor.fm/s/f0076084/podcast/rss","website_url":"https://podcasters.spotify.com/pod/show/max-brennan4","image_url":"https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_nologo/40170153/40170153-1775724702970-e7a36a5e3cf58.jpg","author":"Max Brennan - Biotech HeadHunter","episode_count":230,"summary":"Welcome to The BioHub, where the doors to the world of biotechnology swing wide open. Join your host, Max Brennan, a seasoned biotech recruiter, as he engages in thought-provoking conversations with the brightest minds in biotech. This podcast is your backstage pass to the insights, strategies, and stories that fuel success in the dynamic and ever-evolving biotech landscape. Subscribe now and be part of the conversation that's shaping the future of biotechnology. Get ready for an immersive experience into the world of biotech with The BioHub.","last_synced_at":"2026-07-21T04:19:24.893516+00:00","page_url":"https://stenobird.com/podcast/the-biohub-by-avetix-7252289"},"episode":{"title":"Episode 156 - Rafiq Hasan - CEO of Complement Therapeutics","slug":"episode-156-rafiq-hasan-ceo-of-complement-therapeutics","published_at":"2026-04-21T07:48:01+00:00","page_url":"https://stenobird.com/podcast/the-biohub-by-avetix-7252289/episode-156-rafiq-hasan-ceo-of-complement-therapeutics","show_page_url":"https://stenobird.com/podcast/the-biohub-by-avetix-7252289","url":"https://podcasters.spotify.com/pod/show/max-brennan4/episodes/Episode-156---Rafiq-Hasan---CEO-of-Complement-Therapeutics-e3i7ha1","audio_url":"https://anchor.fm/s/f0076084/podcast/play/118784769/https%3A%2F%2Fd3ctxlq1ktw2nl.cloudfront.net%2Fstaging%2F2026-3-21%2F422507405-44100-2-0ca06f96e1165.mp3","summary":"We sit down with Rafiq Hasan, co-founder & CEO of Complement Therapeutics, at their London offices to unpack a milestone-loaded past 6 months. Rafiq shares the company's thesis, based on research from Manchester university, and how in practice they are targeting the complement system. We also dig into a landmark moment for the company - the recent dosing of patients in OPTI-GAIN, their Phase 1/2 clinical trial targeting Geographic Atrophy, a leading cause of irreversible vision loss. Another topic of discussion centers around what it's took to build a biotech from the ground up over the past few challenging years. Definitely worth a listen for anyone building in ophthalmology, gene therapy, or across UK biotech.","meta_description":"We sit down with Rafiq Hasan, co-founder & CEO of Complement Therapeutics, at their London offices to unpack a milestone-loaded past 6 months. Rafiq s…","key_points":[],"chapters":[],"topics":[],"duration_seconds":1259,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-biohub-by-avetix-7252289/episodes/episode-156-rafiq-hasan-ceo-of-complement-therapeutics/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-biohub-by-avetix-7252289/episode-156-rafiq-hasan-ceo-of-complement-therapeutics.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}